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Outcome of Staged Repair of Tetralogy of Fallot with Pulmonary 
Atresia and a Ductus-dependent Pulmonary Circulation: Should 
Primary Repair Be Considered?
Hyungtae  Kim,  M.D.*,  Si  Chan  Sung,  M.D.*,  Yun  Hee  Chang,  M.D.**,  Wonkil  Jung***, 
Hyoung  Doo  Lee,  M.D.****,  Ji  Ae  Park,  M.D.****,  Up  Huh,  M.D.*
Background:  The tetralogy of Fallot (TOF) with pulmonary atresia (PA) and a ductus-dependent pulmonary circu-
lation (no major aorto-pulmonary collateral arteries (MAPCAs)) has been treated with staged repair or primary repair 
depending on the preference of surgeons or institutions. We evaluated the 19-year outcome of staged repair for 
this anomaly to find out whether our surgical strategy should be changed. Materials and Methods: Forty-four pa-
tients with TOF/PA with patent ductus arteriosus (PDA) who underwent staged repair from June 1991 to October 
2010 were included in this retrospective study. The patients with MAPCAs were excluded. The average age at the 
first palliative shunt surgery was 40.8±67.5 days (range: 0∼332 days). Thirty-one patients (31/44, 70%) were 
neonates. The average weight was 3.5±1.6 kg (range: 1.6∼8.7 kg). A modified Blalock-Taussig (BT) shunt was 
performed in 38 patients, classic BT shunt in 4 patients, and central shunt in 2 patients. Six patients required 
concomitant procedures: pulmonary artery angioplasty was performed in 4 patients, pulmonary artery reconstruction 
in one patient, and re-implantation of the left pulmonary artery to the main pulmonary artery in one patient. Four 
patients required a second shunt operation before the definitive repair was performed. Thirty-three patients under-
went definitive repair at 24.2±13.3 months (range: 7.3∼68 months) after the first palliative operation. The average 
age at the time of definitive repair was 25.4±13.5 months (range: 7.6∼68.6 months) and their average weight 
was 11.0±2.1 kg. For definitive repair, 3 types of right ventricular outflow procedures were used: extra-cardiac con-
duit was performed in 30 patients, trans-annular patch in 2 patients, and REV operation in 1 patient. One patient 
was lost to follow-up after hospital discharge. The mean follow-up duration for the rest of the patients was 72±37 
months (range: 4∼160 months). Results: Ten patients (10/44, 22.7%) died before the definitive repair was 
performed. Four of them died during hospitalization after the shunt operation. Six deaths were thought to be 
shunt-related. The average time of shunt-related deaths after shunt procedures was 8.7 months (range: 2 days∼
25.3 months). There was no operative mortality after the definitive repair, but one patient died from dilated car-
diomyopathy caused by myocarditis 8 years and 3 months after the definitive repair. Five-year and 10-year survival 
rates after the first palliative operation were 76.8% and 69.1%, respectively. Conclusion: There was a high overall 
mortality rate in staged repair for the patients with TOF/PA with PDA. Majority of deaths occurred before the de-
finitive repair was performed. Therefore, primary repair or early second stage definitive repair should be considered 
to enhance the survival rate for patients with TOF/PA with PDA.Staged Repair for TOF/PA 
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INTRODUCTION
The  tetralogy  of  Fallot  (TOF)  with  pulmonary  atresia  (PA) 
is  one  extreme  group  among  the  wide  morphologic  spectrum 
of TOF. The patients in this group of cardiac anomalies can-
not  survive  without  a  patent  duct u s  a r t e r i o s u s  ( P D A )  i f  t h e y  
do  not  have  aorto-pulmonary  collateral  arteries.  This  extreme 
group  of  TOF  has  been  traditionally  managed  with  the  shunt 
procedure in the neonatal period or early infancy followed by 
a subsequent definitive repair due to relative unavailability or 
short  longevity  of  a  small  extracardiac  conduit,  technically 
more  demanding  early  primary  repair,  and  difficult  post-
operative management. However, some centers have started to 
perform  a  primary  one-stage  repair  for  this  group  of  cardiac 
anomalies since about 20 years ago [1-4]. Although the num-
ber  of  centers  performing  a  primary  one-stage  repair  is  in-
creasing,  a  large  number  of  centers  are  still  doing  staged  re-
pair  because  of  technical  ease  of  the  operation  and  relative 
unavailability  of  small  extracardiac  conduit  for  neonates. 
However,  staged  repair  has  several  disadvantages:  longer  ex-
posure  to  hypoxemia,  abnormal  growth  of  pulmonary  alveoli 
and vascular structures, pulmonary artery distortion, right ven-
tricular  hypertrophy  or even  fibrosis  due to  pressure and  vol-
ume load on the right ventricle, and a significant attrition rate 
d u e  t o  t h e  s h u n t  p r o b l e m  b e t w e e n  s t a g e s .  T h e  a i m  o f  t h i s  
study is to determine whether our surgical policy for the TOF 
with  PA  and  ductus-dependent  pulmonary  circulation  should 
be changed based on the results of staged repair over the last 
19  years.
MATERIALS AND METHODS
A  retrospective  study  was  conducted  based  on  the  medical 
records  of  44  patients  with  TOF/PA  with  PDA  treated  with 
staged  repair  in  the  Department  of  Thoracic  and 
Cardiovascular  Surgery  at  Dong-A  University  Hospital  and 
Pusan  National  University  Hospital  between  June  1991  and 
October  2010.  The  patients  with  major  aorto-pulmonary  col-
lateral  arteries  (MAPCAs)  were  excluded.  Data  of  survival 
and  death  were  obtained  from  the  National  Statistical  Office. 
The  average  age  at  the  first  systemic-pulmonary  shunt  oper-
ation  was  40.8±67.5  days  (range:  0∼332  days).  Among 
them,  31  patients  (70.5%)  were  neonates,  and  39  patients 
(88.6%)  were  younger  than  90  days  of  age.  The  average 
weight  at  the  time  of  the  shunt  operation  was  3.5±1.6  kg 
(range:  1.6∼8.7  kg).  Associated  significant  intracardiac 
anomalies  were  left  pulmonary  artery  (LPA)  sling  and  partial 
anomalous  pulmonary  venous  return  (PAPVR)  in  one  patient 
each.  Extra-cardiac  anomalies  were  left  lung  hypoplasia  in  1 
patient,  esophageal  atresia  with  anal  atresia  in  1  patient,  anal 
atresia  in  1  patient,  hypospadia  with  Hirschsprung's  disease 
in  1  patient,  and  CATCH22  syndrome  in  2  patients.  All  but 
one  had  confluent  pulmonary  ar t e r i e s .  O n e  p a t i e n t  h a d  a b -
sence  of  intrapericardial  pulmonary  arteries  with  bilateral 
PDA and situs inversus. The main pulmonary artery and pul-
monary  annulus  could  be  inspected  in  32  patients.  Among 
them,  thirty  patients  had  a  main  pulmonary  artery  and  27  of 
these 30 patients had no pulmonary valve. Three patients had 
a membranous PA. Two patients did not have a main pulmo-
nary  artery.  At  first  palliation,  a  right  modified 
Blalock-Taussig (RMBT) shunt was performed in 33 patients, 
right classic Blalock-Taussig (RCBT)  shunt  in 3 patients,  left 
modified  Blalock-Taussig  (LMBT)  shunt  in  5  patients,  left 
classic  Blalock-Taussig  (LCBT)  shunt  in  1  patient,  and  cen-
tral shunt in 2 patients. Six patients required concomitant pro-
cedures: pulmonary artery angioplasty was performed in 4 pa-
tients,  pulmonary  artery  reconstruction  in  1  patient,  and 
re-implantation  of  the  left  pulmonary  artery  to  the  main  pul-
m o n a r y  a r t e r y  i n  1  p a t i e n t .  F o ur  patients  required  another 
systemic-pulmonary shunt or revision before the definitive re-
pair  was  performed.  Three  of  them  required  a  second  proce-
dure due to hypoplastic LPA: one underwent an LMBT shunt 
as  a  second  shunt  operation  at  17.4  months  after  the  first 
shunt operation, and the other two patients underwent a shunt Hyungtae Kim, et al
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Table 1. Causes of second shunt procedures
Patient 
no.
Previous  operation Second  shunt  procedure
Time  after 
1st  operation 
(months)
Reasons  for  2nd  operation
1
2
3
4
RMBTS
RMBTS  with  LPA  angioplasty
RMBTS  with  LPA  angioplasty
PA  conduit  reconstruction  with 
central  shunt
LMBTS
Shunt  change  with  LPA  angioplasty
Shunt  change  with  LPA  angioplasty
PA  conduit  change  with  LMBTS
17.4
5
8
6
Hypoplastic  LPA  with  juxtaductal 
stenosis
Hypoplastic  LPA  with  LPA  restenosis
Hypoplastic  LPA  with  LPA  restenosis
PA  conduit  stenosis
RMBTS=Right  modified  Blalock-Taussig  shunt;  LMBTS=Left  modified  Blalock-Taussig  shunt;  LPA=Left  pulmonary  artery; 
PA=Pulmonary  artery.
Table 2. T ypes of conduits used in definitive operations in our 
hospital (n=25/27 patients)
Type  of  conduit No.  of  patient
Polystan  porcine  pericardium  valved  conduit
Selhigh  porcine  valved  conduit
Homemade  gore-tex  valved  conduit
  M o n o c u s p
  B i c u s p
  T r i c u s p
Total
10
 4
11
 3
 7
 1
25
Six  patients  (6/33)  were  excluded  because  they  underwent  de-
f i n i t i v e  r e p a i r  a t  t h e  o t h e r  c e n t e r s .
Table 3. Conduit changes after the definitive repair (n=4)
Patient 
no.
Period  after  the 
definitive  repair
Operation
1
2
3
4
5  years  and  1  month
4  years  and  6  months
7  years
8  years  and  4  months
Conduit  change  with  VSD 
closure
RVOT  reconstruction  with-
out  valve  (peel  operation)
PVR  (peel  operation)
PVR  (peel  operation)
VSD=Ventricular  septal  defect;  RVOT=Right  ventricular  out-
flow  tract;  PVR=Pulmonary  valve  replacement.
r e v i s i o n  ( c h a n g e )  w i t h  L P A  a ngioplasty  at  5  months  and  8 
months  after  the  first  shunt  operation  respectively  due  to 
re-stenosis  of  the  concomitant  LPA  angioplasty  site  of  the 
first  RMBT  shunt  procedure.  The  remaining  one  patient  was 
the  case  with  absence  of  intrapericardial  pulmonary  artery.  A 
PA  conduit  change  with  LMBT  shunt  was  performed  at  6 
m o n t h s  a f t e r  t h e  f i r s t  o p e r a t i o n  ( T a b l e  1 ) .
A  total  of  33  (75%)  of  44  patients  underwent  definitive 
repair.  Six  of  those  33  patients underwent  definitive  repair  at 
other centers. The average age at the time of definitive repair 
was  25.4±13.5  months  (range:  7.6∼68.6  months)  and  the 
average  weight  was  11.0±2.1  kg  (n=27).  The  time  interval 
between  definitive  repair  and  the  first  shunt  operation  was 
24.2±13.3  months  (range:  7.3∼68  months).  Right  ventricular 
outflow  tract  (RVOT)  reconstruction  with  extra-cardiac  con-
duits  for  the  definitive  repair  was  performed  in  30  patients, 
transannular  patch  repair  in  2  patients,  and  an  REV-type  op-
eration  in  1  patient.  Ventricular  septal  defect  (VSD)  patch 
fen estr atio n w as r equir ed in 2 p atients. Polystan porcine peri-
cardium  valved  conduits  were  used  in  10  patients,  Selhigh 
porcine  valved  conduits  in  4  patients,  and  homemade 
Gore-Tex  valved  conduits  in  11  patients  (Table  2).  Various 
sizes o f co ndu its w er e used: 14  mm in 2  patien ts,  16 m m in 
11 patients, and 18 mm in 12 patients. Four patients required 
an RVOT conduit change at 54, 61, 84, and 100 months after 
the  definitive  repair  (Table  3).  Follow-up  data  was  obtained 
in  43  patients,  and  the  average  duration  of  follow-up  was 
72±37  months  (range:  4∼160  months).  One  case  was  in-
terpreted  as  a  loss  to  follow-up.  This  patient  had  been  dis-
charged  from  the  hospital  without  any  significant  problems, 
but  no  more  information  could  be  collected  because  the  pa-
r e n t s  o f  t h e  p a t i e n t  d i d  n o t  c o o p e r a t e  i n  p r o v i d i n g  a n y  i n -
formation  after  discharge. 
All  results are expressed as  means±standard deviations  and 
the Kaplan-Meier model was used to analyze the survival rate 
and  freedom  from  extra-cardiac  conduit  change.   Staged Repair for TOF/PA 
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Table 4. Causes of hospital deaths
Operation  date Age  Weight  (kg) Associated  anomaly
Time  to 
death
Causes  of  death
Shunt-related 
death
1994-03-22
1995-08-14
1996-03-29
2004-03-22
13  days
14  days
 7  d a y s
 3  m o n t h s
2.6
2.6
3.6
2.1
None
None
Left  lung  hypoplasia
LPA  sling  with  left  main 
  tracheal  stenosis
 2  d a y s
53  days
37  days
  2  hours
Sepsis,  very  small  PA,  hypoxemia
Lung  problem
Multiorgan  failure
Sudden  cardiac  arrest 
  (bradycardia)
(＋)
(−)
(−)
(＋)
LPA=Left  pulmonary  artery;  PA=Pulmonary  artery.
Table 5. Inter-stage deaths between the shunt operation and definitive repair
Operation  date Age  at  operation Weight  (kg)
Associated 
anomaly
Time  to 
death 
(months)
Modes  of  death
Shunt-related 
death
1991-06-01
1996-01-30
1996-08-08
1997-01-10
2005-09-20
2007-12-26
13  days
4  months  27  days
2  months
9  months
4  days
23  days
2.2
7.8
4.0
7.8
3.03
2.18
None
None
None
None
None
Esophageal  atresia, 
 a n a l  a t r e s i a
35.5
16.5
 0 . 9  
 3 . 9
25.3
 7 . 6
D u r i n g  a d m i s s i o n  f o r  c a r d i a c  
 c a t h e t e r i z a t i o n
Brain  damage  after  asphyxia
D O A  ( s u d d e n  d e a t h )
D O A  ( s u d d e n  d e a t h )
Nephrotic  syndrome,  pneumonia
Sudden  death
Death  during  colostomy  repair
(−)
(＋)
(＋)
(−)
(＋)
(＋)
DOA=Death  on  arrival.
RESULTS
There  were  4  hospital  deaths  (9.1%)  after  the  shunt 
procedure.  Two  were  considered  shunt-related  deaths.  One  of 
them  underwent  a  central  shunt  and  reimplantation  of  the 
L P A  f o r  s u b c a r i n a l  L P A  s l i n g  w i t h  l e f t  m a i n  b r o n c h u s  
stenosis. She was a premature low birth weight baby (1,190 g 
at  birth,  and  2,100  g  at  operation).  Soon  after  arrival  at  the 
intensive care unit (ICU) after surgery, bradycardia and hypo-
tension  developed  and  in  the e n d  s h e  d i e d  d e s p i t e  c a r -
dio-pulmonary  resuscitation  (CPR).  Another  one  had  a  se-
verely hypoplastic pulmonary artery. Even after the shunt op-
eration,  mild  hypoxemia  persisted,  and  as  a  consequence,  the 
patient died of hypoxemia 2 days after surgery. There were 2 
non-shunt-related  hospital  deaths.  One  died  of  lung  problems 
during  long-term  ventilator  care  at  53  days  after  operation. 
The  other  patient  had  a  hypoplastic  left  lung  and  had  been 
given ventilator care since birth, and was never weaned from 
it.  The  death  was  caused  by  multiple  organ  failure  followed 
by  sepsis  at  37  days  after  opera t i o n  ( T a b l e  4 ) .  S i x  p a t i e n t s  
(6/43, 14.0%) died between the shunt operation and definitive 
repair,  known  as  inter-stage  death.  Four  deaths  were  consid-
ered  to  be  shunt-related  deaths.  The  inter-stage  deaths  oc-
curred  at  0.9,  7.6,  16.5,  and  25.3  months  after  the  shunt 
operation.  Three  of  them  were  sudden  deaths.  One  patient 
died  soon after  colostomy  repair.  Two cases  were  not related 
to  shunt  operations.  One  patient  died  of  hypoxic  brain  dam-
age  caused  by  asphyxia  during  hospitalization  for  cardiac 
catheterization  at  35.5  months  after  shunt  operation.  Another 
patient  died  of  nephrotic  syndrome  and  pneumonia  at  3.9 
months  after  shunt  operation  (Table  5).  Six  deaths  (13.6%) 
among  the  overall  10  mortalities  (22.7%)  were  considered  to 
be  shunt-related.  Shunt-related  deaths  occurred  at  an  average 
period  of  8.7  months  (range:  2  days∼25.3  months)  after  the 
shunt operation. Definitive repair was performed in 33 (75%) 
out  of  a  total  of  44  patients  at  an  average  period  of  24.2 
months  (range:  7.3∼68  months)  after  the  shunt  operation, 
and  there  was  no  operative  mortality  after  the  definitive Hyungtae Kim, et al
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Fig. 1. Freedom from conduit change. Fig. 2. Cumulative survivals.
repair.  One  patient  died  from  dilated  cardiomyopathy  caused 
by  myocarditis  at  8  years  and  3  months  after  the  definitive 
repair.  In  the  25  patients  who  had  undergone  the  ex-
tra-cardiac  conduit  technique  at  our  center,  freedom  from  ex-
tra-cardiac  conduit  change  was  94.7%  at  5  years  and  64.6% 
at  10  years  (Fig.  1).  Overall,  the  five-year  survival  rate  was 
76.8%  and  10-year  survival  rate  was  69.1%  (Fig.  2).
DISCUSSION
Staged  surgical  management  for  the  spectrum  of  TOF  has 
been  a  standard  procedure  for  many  years.  Particularly,  the 
staged  surgical  approach  has  been  recommended  for  infants 
under  1  year  of  age  and  infants  with  unfavorable  anatomy 
[5,6].  However,  the  debate  over  staged  repair  and  early  total 
correction  continues.  Therefore,  surgical  data  of  44  patients 
with  TOF/PA  with  PDA  who  received  staged  surgical  man-
agement  in  the  last  19  years  were  studied  to  clarify  the  best 
surgical  strategy  for  this  specific  cardiac  anomaly.
Since  Blalock  and  Taussig  introduced  the  palliative  BT 
shunt,  this  surgical  management  technique  has  been  actively 
p e r f o r m e d  a n d  h a s  s a v e d  t h e  l i v es  of  a  large  number  of  pa-
tients  with  complex  heart  diseases  and  decreased  pulmonary 
blood flow. It has been considered to have several advantages 
such  as  low  risk,  effective  palliation,  and  pulmonary  artery 
growth [7]. In 1981, it was reported that the BT shunt is pre-
ferred because it is safe, gives good sustained clinical results, 
and has low mortality and good growth of the pulmonary ar-
teries  without  an  increase  in  pulmonary  vascular  resistance 
[8].  After  the  modified  BT  shunt  was  developed,  the  pallia-
tive  shunt  operation  has  been  accepted  as  a  standard  proce-
dure  for  this  congenital  heart  disease.  For  about  half  a  cen-
tury,  the  modified  BT  shunt  has  been  the  most  effective  pal-
liative  procedure  due  to  its  advantages,  including  a  techni-
cally  simpler  method  with  less  dissection  and  better  blood 
flow  to  the  respective  arm  compared  to  the  classic  BT  shunt 
[9].  In  this  study,  the  modified  BT  shunt  was  performed  as 
the  first  stage  palliation  in  most  patients  (38/44,  86.4%).  We 
adopted  the  classic  BT  shunt  in  small  neonates  and  patients 
with a very small pulmonary artery during the early phase of 
our  series. 
However,  as  time  has  passed,  the  risk  associated  with  BT 
shunt has been studied and serious problems due to the shunt 
operation  have  been  discussed.  After  the  shunt  operation,  for 
whatever  reason,  management  of  decreased  pulmonary  blood 
flow  is  technically  demanding  [10].  The  major  cause  of  de-
creased  pulmonary  blood  flow  is  known  to  be  shunt 
obstruction.  Shunt  thrombosis  and  occlusion  could  give  rise 
to  sudden  and  fatal  conditions,  and  increased-morbidity  and 
mortality after the modified BT shunt are associated with fac-
tors such as age, pulmonary artery diameter, and baseline car-
diac  anatomy  [11].  Shunt  failure followed  by  shunt  occlusion 
is infrequent but once it occurs, it often leads to a life-threat-
ening  condition  [12].  This  problem  is  far  more  significant  in Staged Repair for TOF/PA 
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T O F  w i t h  p u l m o n a r y  a t r e s i a  u n l i k e  T O F  w i t h  P S ,  w h i c h  h a s  
an  alternative  pulmonary  blood  source.  In  our  study,  the  ma-
jor  causes  of  death  before  the  definitive  repair  were 
shunt-related.  More  specific  causes  of  hospital  deaths  are  de-
s c r i b e d  i n  T a b l e  4 .  T h i s  s h o w s  t h a t  h a l f  o f  h o s p i t a l  d e a t h s  
(2/4)  seemed  to  be  shunt-related. A f t e r  t h e  i n i t i a l  p a l l i a t i v e  
shunt  operation,  6  patients  (6/43,  14.0%)  died  before  the  de-
finitive  repairs  was  performed,  which  has  been  called  in-
ter-stage  death  or  attrition.  Four  of  the  6  cases  of  inter-stage 
death  were  sudden  deaths.  Shunt  failure  due  to  shunt  occlu-
sion is strongly suspected in these cases. Therefore, it can be 
s a i d  t h a t  t h e  s t a t u s  a f t e r  t h e  s h u n t  o p e r a t i o n  i s  n o t  s a f e ,  a n d  
it  can  significantly  contribute  to  the  overall  morality  in  pa-
tients  with  TOF/PA  with  PDA.
Due  to  the  problems  mentioned  above,  although  the  BT 
shunt  and  modified  BT  shunt  could  be  considered  a  low-risk 
management option for palliation for the spectrum of TOF, it 
can  pose  a  significant  challenge  in  patient  care  [13].  As  a 
consequence,  early  one-stage  total  repair  or  early  definitive 
repair  after  the  initial  palliative  surgery  is  being  discussed  as 
an  alternative  to  staged  repair. 
Advantages  of  early  definitive  repair  include  removal  of 
the  stimulus  for  right  ventricular  hypertrophy,  alleviation  of 
cyanosis and preservation of myocardial mechanical and elec-
trical  function. Early  definitive repair  is  also  helpful  to  avoid 
the  risks  associated  with  shunt  operation  such  as  an  unstable 
hemodynamic  status  due  to  excessive  or  insufficient  pulmo-
nary  blood  flow  in  the  immediate  postoperative  period,  sud-
den  inter-stage  mortality  due  to  occlusion  or  critical  stenosis 
of the shunt, distortion of the pulmonary artery branch at the 
shunt insertion site [2,11,14]. Recently, excellent outcomes of 
one-stage  total  repair  have  been  reported.  In  1999,  a  clear 
survival  advantage  of  primary  repair  was  demonstrated  by 
Van Arsdell and Yun [14]. In the same year, Pigula and col-
leagues  reported  that  early  complete  repair  could  be  accom-
plished with low mortality and low freedom from reoperation 
in neonates [15]. Moreover, the problems of challenging post-
operative  care  and  limitation  of  conduit  size  used  are  also 
getting  solved  by  the  evolution  of  surgical  and medical  man-
agement, such that the morbidity and mortality of early com-
p l e t e  r e p a i r  f o r  t h e  s p e c t r u m  o f  T O F  h a s  i m p r o v e d  [ 4 ] .  
Furthermore,  early  complete  repair  also  has  short-term  bene-
fits  (low  risk  for  reoperation  and  re-intervention),  excellent 
intermediate survival, and long-term benefits (better right ven-
tricular  function  and  lower  arrhythmia)  [1,4,15].  A  com-
parative  study  between  staged  repair  and  the  early  complete 
repair  was  reported  by  Park  and  colleagues  [4].  However, 
e a r l y  c o m p l e t e  r e p a i r  f o r  s m a l l  n e o n a t e s  o r  n e o n a t e s  w i t h  a  
small pulmonary artery is still challenging because of the dif-
ficult  operative  techniques  and  shortage  of  adequate  ex-
tracardiac  conduits.  We  believe  that  the  RV-PA  conduit,  in-
stead  of  complete  repair,  can  be  an  alternative  for  short-term 
palliation  [16].
Another  important  conclusion  could  be  derived  from  Table 
5, the column for ‘time to attrition’. A total of four shunt-re-
lated  attritions  (inter-stage  deaths)  were  reported  and  their 
times  to  attrition  were  16.5,  0.9,  25.3,  and  7.6  months.  In 
other  words,  if  the  second-stage  definitive  repair  was  con-
ducted  earlier  than  6  months  after  the  first-stage  palliative 
shunt  operation,  3  patients  could  have  survived.
In conclusion, there are two surgical strategies that are rec-
ommended  in  patients  with  TOF/PA  with  PDA  to  increase 
the  overall  survival  rate.  Firstly,  an  early  complete  repair 
could be a favorable option. Secondly, in staged management, 
earlier  second-stage  definitive  repair  after  the  palliative  shunt 
procedure  should  be  considered,  or  another  palliative  proce-
dure  other  than  the  shunt  procedure,  such  as  an  RV-PA  con-
duit,  should  be  adopted. 
1) Study Limitations
Several  limitations  of  the  present  study  require 
consideration.  In  our  study,  we  did  not  compare  the  outcome 
of  primary  repair  and  the  outcome  of  staged  repair. 
Therefore,  we  do  not  vouch  for  the  benefit  of  early  primary 
repair  over  staged  repair,  but  we  did  note  that  mortality  was 
high  after  the  first  palliative  operations.  Several  authors  have 
reported  the  benefits  of  early  complete  repair  for  the  spec-
trum  of  TOF  [1,4,14,15].  We  concluded  that  primary  repair 
for  TOF/PA  and  ductus  dependent  pulmonary  circulation  is  a 
good  option.  The  other  limitation  is  that  our  study  does  not 
include  patients  with  diminutive  pulmonary  arteries.Hyungtae Kim, et al
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CONCLUSION
The overall survival rate in the patients with TOF/PA with 
PDA  was  relatively  low  after  staged  repair  due  to  high  in-
ter-stage  mortality  after  the  shunt  operation.  Therefore,  early 
complete  repair  or  early  second-stage  definitive  repair  after 
the  palliative  shunt  procedure  should  be  considered  to  in-
crease  the overall survival rate in patients with TOF/PA  with 
PDA.
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